Influence of dietary phytochemicals and microbiota on colon cancer risk

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 27, 2012, Pages 6728-6735

  MacDonald, Ruth S ^a   Wagner, Kelly ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

bioactive components; colon cancer; diet; estrogen receptor; polyphenols

Indexed keywords

BIOACTIVE COMPONENTS; BIOACTIVE COMPOUNDS; CELLULAR EVENTS; CELLULAR REGULATION; COLON CANCER; DIETARY COMPONENTS; DIETARY PATTERNS; ESTROGEN RECEPTOR; MICROBIAL POPULATIONS; MICROBIOTAS; PHYTOCHEMICALS; POLYPHENOLS;

MICROORGANISMS; NUTRITION; PHENOLS;

DISEASES;

PLANT MEDICINAL PRODUCT;

ANIMAL; ARTICLE; COLON TUMOR; DIET SUPPLEMENTATION; DRUG EFFECT; HUMAN; MICROBIOLOGY; MICROFLORA; RISK FACTOR;

ANIMALS; COLONIC NEOPLASMS; DIETARY SUPPLEMENTS; HUMANS; MICROBIOTA; PHYTOCHEMICALS; RISK FACTORS;

EID: 84863944854     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf204230r     Document Type: Article

References (100)

1. Watson, A. J.; Collins, P. D. Colon cancer: a civilization disorder Dig. Dis. 2011, 29, 222-228
2. Research, W. C. R. F. a. A. I. f. C. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective; AICR: Washington, DC, 2007.
3. Chan, D. S.; Lau, R.; Aune, D.; Vieira, R.; Greenwood, D. C.; Kampman, E.; Norat, T. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies PLoS One 2011, 6, e20456
4. Alexander, D. D.; Weed, D. L.; Cushing, C. A.; Lowe, K. A. Meta-analysis of prospective studies of red meat consumption and colorectal cancer Eur. J. Cancer Prev. 2011, 20, 293-307
5. Williams, C. D.; Satia, J. A.; Adair, L. S.; Stevens, J.; Galanko, J.; Keku, T. O.; Sandler, R. S. Associations of red meat, fat, and protein intake with distal colorectal cancer risk Nutr. Cancer 2010, 62, 701-709
6. Burkitt, D. P.; Walker, A. R.; Painter, N. S. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease Lancet 1972, 2, 1408-1412
7. Haas, P.; Machado, M. J.; Anton, A. A.; Silva, A. S.; De Francisco, A. Effectiveness of whole grain consumption in the prevention of colorectal cancer: meta-analysis of cohort studies Int. J. Food Sci. Nutr. 2009, 1-13
8. Tantamango, Y. M.; Knutsen, S. F.; Beeson, W. L.; Fraser, G.; Sabate, J. Foods and food groups associated with the incidence of colorectal polyps: the Adventist Health Study Nutr. Cancer 2011, 63, 565-572
9. Butt, M. S.; Sultan, M. T. Green tea: nature's defense against malignancies Crit. Rev. Food Sci. Nutr. 2009, 49, 463-473
10. Yan, L.; Spitznagel, E. L.; Bosland, M. C. Soy consumption and colorectal cancer risk in humans: a meta-analysis Cancer Epidemiol. Biomarkers Prev. 2010, 19, 148-158
11. Gala, M.; Chung, D. C. Hereditary colon cancer syndromes Semin. Oncol. 2011, 38, 490-499
12. Fearon, E. R. Molecular genetics of colorectal cancer Annu. Rev. Pathol. 2011, 6, 479-507
13. Leedham, S. J.; Rodenas-Cuadrado, P.; Howarth, K.; Lewis, A.; Mallappa, S.; Segditsas, S.; Davis, H.; Jeffery, R.; Rodriguez-Justo, M.; Keshav, S.; Travis, S. P.; Graham, T. A.; East, J.; Clark, S.; Tomlinson, I. P. A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts Gut 2012, 10.1136/gutjnl-2011-301601
14. Lu, Q.; Jiang, B.; Lin, C.; Shan, T. Dark aberrant crypt foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat J. Exp. Clin. Cancer Res. 2008, 27, 26
15. Vaish, V.; Sanyal, S. N. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling Biomed. Pharmacother. 2012, 10.1016/j.biopha.2012.01.004
16. Tarapore, R. S.; Siddiqui, I. A.; Mukhtar, H. Modulation of Wnt/β-catenin signaling pathway by bioactive food components Carcinogenesis 2012, 33, 483-491
17. Link, A.; Balaguer, F.; Goel, A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics Biochem. Pharmacol. 2010, 80, 1771-1792
18. Davis, C. D.; Emenaker, N. J.; Milner, J. A. Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer Semin. Oncol. 2010, 37, 243-257
19. Ullman, T. A.; Itzkowitz, S. H. Intestinal inflammation and cancer Gastroenterology 2011, 140, 1807-1816
20. Jain, S. S.; AshokKumar, M.; Bird, R. P. Differential expression of TNF-α signaling molecules and ERK1 in distal and proximal colonic tumors associated with obesity Tumour Biol. 2011, 32, 1005-1012
21. Slattery, M. L.; Herrick, J. S.; Bondurant, K. L.; Wolff, R. K. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis Int. J. Cancer 2011, 10.1002/ijc.26314
22. Marteau, P.; Chaput, U. Bacteria as trigger for chronic gastrointestinal disorders. Dig. Dis. 2011, 29, 166-171.
23. Blumberg, R. Inflammation in the intestinal tract: pathogenesis and treatment Dig. Dis. 2009, 27, 455-464
24. Jawad, N.; Direkze, N.; Leedham, S. J. Inflammatory bowel disease and colon cancer Recent Results Cancer Res. 2011, 185, 99-115
25. Rizzo, A.; Pallone, F.; Monteleone, G.; Fantini, M. C. Intestinal inflammation and colorectal cancer: a double-edged sword? World J. Gastroenterol. 2011, 17, 3092-3100
26. Logan, I.; Bowlus, C. The geoepidemiology of autoimmune intestinal diseases Autoimmun. Rev. 2010, 9, A372-A378
27. Malaty, H.; Fan, X.; Opekun, A.; Thibodeaux, C.; Ferry, G. Rising incidence of inflammatory bowel disease among children: a 12-year study J. Pediatr. Gastroenterol. Nutr. 2010, 50, 27-31
28. Mattar, M. C.; Lough, D.; Pishvaian, M. J.; Charabaty, A. Current management of inflammatory bowel disease and colorectal cancer Gastrointest. Cancer Res. 2011, 4, 53-61
29. Araki, Y.; Mukaisyo, K.; Sugihara, H.; Fujiyama, Y.; Hattori, T. Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice Oncol. Rep. 2010, 24, 869-874
30. Pozza, A.; Scarpa, M.; Ruffolo, C.; Polese, L.; Erroi, F.; Bridda, A.; Norberto, L.; Frego, M. Colonic carcinogenesis in IBD: molecular events Ann. Ital. Chir. 2011, 82, 19-28
31. Huls, G.; Koornstra, J. J.; Kleibeuker, J. H. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas Lancet 2003, 362, 230-232
32. Koehne, C. H.; Dubois, R. N. COX-2 inhibition and colorectal cancer Semin. Oncol. 2004, 31, 12-21
33. Zhu, Y.; Michelle Luo, T.; Jobin, C.; Young, H. A. Gut microbiota and probiotics in colon tumorigenesis Cancer Lett. 2011, 309, 119-127
34. Azcárate-Peril, M. A.; Sikes, M.; Bruno-Bárcena, J. M. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301, G401-G424
35. Guarner, F. The intestinal flora in inflammatory bowel disease: normal or abnormal? Curr. Opin. Gastroenterol. 2005, 21, 414-418
36. Moore, W. E.; Moore, L. H. Intestinal floras of populations that have a high risk of colon cancer Appl. Environ. Microbiol. 1995, 61, 3202-3207
37. Davis, C. D.; Milner, J. A. Gastrointestinal microflora, food components and colon cancer prevention J. Nutr. Biochem. 2009, 20, 743-752
38. De Preter, V.; Raemen, H.; Cloetens, L.; Houben, E.; Rutgeerts, P.; Verbeke, K. Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities Eur. J. Clin. Nutr. 2008, 62, 225-231
39. Azcarate-Peril, M. A.; Sikes, M.; Bruno-Barcena, J. M. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301 (3), G401-G424.
40. Corazziari, E. Intestinal mucus barrier in normal and inflamed colon J. Pediatr. Gastroenterol. Nutr. 2009, 48 (Suppl. 2) S54-S55
41. Degirolamo, C.; Modica, S.; Palasciano, G.; Moschetta, A. Bile acids and colon cancer: solving the puzzle with nuclear receptors Trends Mol. Med. 2011, 17, 564-572
42. O'Keefe, S. J. Nutrition and colonic health: the critical role of the microbiota Curr. Opin. Gastroenterol. 2008, 24, 51-58
43. Havenaar, R. Intestinal health functions of colonic microbial metabolites: a review Benef. Microbes 2011, 2, 103-114
44. Russell, W.; Duthie, G. Plant secondary metabolites and gut health: the case for phenolic acids Proc. Nutr. Soc. 2011, 70, 389-396
45. Namasivayam, N. Chemoprevention in experimental animals Ann. N.Y. Acad. Sci. 2011, 1215, 60-71
46. Rimando, A. M.; Suh, N. Biological/chemopreventive activity of stilbenes and their effect on colon cancer Planta Med. 2008, 74, 1635-1643
47. Kineman, B. D.; Brummer, E. C.; Paiva, N. L.; Birt, D. F. Resveratrol from transgenic alfalfa for prevention of aberrant crypt foci in mice Nutr. Cancer 2010, 62, 351-361
48. Miene, C.; Weise, A.; Glei, M. Impact of polyphenol metabolites produced by colonic microbiota on expression of COX-2 and GSTT2 in human colon cells (LT97) Nutr. Cancer 2011, 63, 653-662
49. Kang, N. J.; Lee, K. W.; Kim, B. H.; Bode, A. M.; Lee, H. J.; Heo, Y. S.; Boardman, L.; Limburg, P.; Dong, Z. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK Carcinogenesis 2011, 32, 921-928
50. Singh, B. N.; Shankar, S.; Srivastava, R. K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications Biochem. Pharmacol. 2011, 82 (12) 1807-1821
51. Zhang, X.; Albanes, D.; Beeson, W. L.; van den Brandt, P. A.; Buring, J. E.; Flood, A.; Freudenheim, J. L.; Giovannucci, E. L.; Goldbohm, R. A.; Jaceldo-Siegl, K.; Jacobs, E. J.; Krogh, V.; Larsson, S. C.; Marshall, J. R.; McCullough, M. L.; Miller, A. B.; Robien, K.; Rohan, T. E.; Schatzkin, A.; Sieri, S.; Spiegelman, D.; Virtamo, J.; Wolk, A.; Willett, W. C.; Zhang, S. M.; Smith-Warner, S. A. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies J. Natl. Cancer Inst. 2010, 102, 771-783
52. Kyle, J. A.; Sharp, L.; Little, J.; Duthie, G. G.; McNeill, G. Dietary flavonoid intake and colorectal cancer: a case-control study Br. J. Nutr. 2010, 103, 429-436
53. Gibellini, L.; Pinti, M.; Nasi, M.; Montagna, J. P.; De Biasi, S.; Roat, E.; Bertoncelli, L.; Cooper, E. L.; Cossarizza, A. Quercetin and cancer chemoprevention Evidence-Based Complement. Alternat. Med. 2011, 10.1093/ecam/meq053
54. Shehzad, A.; Wahid, F.; Lee, Y. S. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials Arch. Pharm. (Weinheim) 2010, 343, 489-499
55. Carroll, R. E.; Benya, R. V.; Turgeon, D. K.; Vareed, S.; Neuman, M.; Rodriguez, L.; Kakarala, M.; Carpenter, P. M.; McLaren, C.; Meyskens, F. L.; Brenner, D. E. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia Cancer Prev. Res. (Phila.) 2011, 4, 354-364
56. Bartik, L.; Whitfield, G. K.; Kaczmarska, M.; Lowmiller, C. L.; Moffet, E. W.; Furmick, J. K.; Hernandez, Z.; Haussler, C. A.; Haussler, M. R.; Jurutka, P. W. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention J. Nutr. Biochem. 2010, 21, 1153-1161
57. Rauch, M.; Lynch, S. The potential for probiotic manipulation of the gastrointestinal microbiome Curr. Opin. Biotechnol. 2012, 23 (2) 192-201
58. Moayyedi, P.; Ford, A. C.; Talley, N. J.; Cremonini, F.; Foxx-Orenstein, A. E.; Brandt, L. J.; Quigley, E. M. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review Gut 2010, 59, 325-332
59. Boirivant, M.; Strober, W. The mechanism of action of probiotics Curr. Opin. Gastroenterol. 2007, 23, 679-692
60. Vanderpool, C.; Yan, F.; Polk, D. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases Inflamm. Bowel Dis. 2008, 14, 1585-1596
61. Capurso, G.; Marignani, M.; Delle Fave, G. Probiotics and the incidence of colorectal cancer: when evidence is not evident Dig. Liver Dis. 2006, 38 (Suppl. 2) S277-S282
62. Masood, M. I.; Qadir, M. I.; Shirazi, J. H.; Khan, I. U. Beneficial effects of lactic acid bacteria on human beings Crit. Rev. Microbiol. 2011, 37, 91-98
63. De Preter, V.; Hamer, H. M.; Windey, K.; Verbeke, K. The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? Mol. Nutr. Food Res. 2011, 55, 46-57
64. De Preter, V.; Falony, G.; Windey, K.; Hamer, H. M.; De Vuyst, L.; Verbeke, K. The prebiotic, oligofructose-enriched inulin modulates the faecal metabolite profile: an in vitro analysis Mol. Nutr. Food Res. 2010, 54, 1791-1801
65. Kelly, G. Inulin-type prebiotics - a review: part 1 Altern. Med. Rev. 2008, 13, 315-329
66. Videla, S.; Vilaseca, J.; Antolín, M.; García-Lafuente, A.; Guarner, F.; Crespo, E.; Casalots, J.; Salas, A.; Malagelada, J. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat Am. J. Gastroenterol. 2001, 96, 1486-1493
67. Fotiadis, C. I.; Stoidis, C. N.; Spyropoulos, B. G.; Zografos, E. D. Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer World J. Gastroenterol. 2008, 14, 6453-6457
68. Gallaher, D. D.; Khil, J. The effect of synbiotics on colon carcinogenesis in rats J. Nutr. 1999, 129, 1483S-1487S
69. Louis, P.; Scott, K.; Duncan, S.; Flint, H. Understanding the effects of diet on bacterial metabolism in the large intestine J. Appl. Microbiol. 2007, 102, 1197-1208
70. Van Loo, J.; Clune, Y.; Bennett, M.; Collins, J. K. The SYNCAN project: goals, set-up, first results and settings of the human intervention study Br. J. Nutr. 2005, 93 (Suppl. 1) S91-S98
71. Pool-Zobel, B. L.; Sauer, J. Overview of experimental data on reduction of colorectal cancer risk by inulin-type fructans J. Nutr. 2007, 137, 2580S-2584S
72. Aksoy, N.; Akinci, O. Mucin macromolecules in normal, adenomatous, and carcinomatous colon: evidence for the neotransformation Macromol. Biosci. 2004, 4, 483-496
73. Rodríguez-Cabezas, M. E.; Camuesco, D.; Arribas, B.; Garrido-Mesa, N.; Comalada, M.; Bailón, E.; Cueto-Sola, M.; Utrilla, P.; Guerra-Hernández, E.; Pérez-Roca, C.; Gálvez, J.; Zarzuelo, A. The combination of fructooligosaccharides and resistant starch shows prebiotic additive effects in rats Clin. Nutr. 2010, 29, 832-839
74. Jahan-Mihan, A.; Luhovyy, B. L.; Khoury, D. E.; Anderson, G. H. Dietary proteins as determinants of metabolic and physiologic functions of the gastrointestinal tract Nutrients 2011, 3, 574-603
75. Peace, R. M.; Campbell, J.; Polo, J.; Crenshaw, J.; Russell, L.; Moeser, A. Spray-dried porcine plasma influences intestinal barrier function, inflammation, and diarrhea in weaned pigs. J. Nutr. 2011, 141, 1312-1317.
76. Alander, M.; Satokari, R.; Korpela, R.; Saxelin, M.; Vilpponen-Salmela, T.; Mattila-Sandholm, T.; von Wright, A. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption Appl. Environ. Microbiol. 1999, 65, 351-354
77. Sprong, R.; Schonewille, A.; van der Meer, R. Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: role of mucin and microbiota J. Dairy Sci. 2010, 93, 1364-1371
78. de Mejia, E.; Dia, V. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-κ pathway in the macrophage Peptides 2009, 30, 2388-2398
79. Lundin, E.; Zhang, J.; Huang, C.; Reuterving, C.; Hallmans, G.; Nygren, C.; Stenling, R. Oat bran, rye bran, and soybean hull increase goblet cell volume density in the small intestine of the golden hamster. A histochemical and stereologic light-microscopic study Scand. J. Gastroenterol. 1993, 28, 15-22
80. Guo, J. Y.; Li, X.; Browning, J. D.; Rottinghaus, G. E.; Lubahn, D. B.; Constantinou, A.; Bennink, M.; MacDonald, R. S. Dietary soy isoflavones and estrone protect ovariectomized ERαKO and wild-type mice from carcinogen-induced colon cancer J. Nutr. 2004, 134, 179-182
81. Barone, M.; Lofano, K.; De Tullio, N.; Licino, R.; Albano, F.; Di Leo, A. Dietary, endocrine, and metabolic factors in the development of colorectal cancer J. Gastrointest. Cancer 2012, 43, 13-19
82. Gallo, D.; De Stefano, I.; Prisco, M. G.; Scambia, G.; Ferrandina, G. Estrogen receptor β in cancer: an attractive target for therapy Curr. Pharm. Des. 2012, 18 (19) 2734-2757
83. Acconcia, F.; Marino, M. The effects of 17β-estradiol in cancer are mediated by estrogen receptor signaling at the plasma membrane Front. Physiol. 2011, 2, 30
84. Björnström, L.; Sjöberg, M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes Mol. Endocrinol. 2005, 19, 833-842
85. McMichael, A. J.; Potter, J. D. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis J. Natl. Cancer Inst. 1980, 65, 1201-1207
86. Fiorelli, G.; Picariello, L.; Martineti, V.; Tonelli, F.; Brandi, M. L. Functional estrogen receptor beta in colon cancer cells Biochem. Biophys. Res. Commun. 1999, 261, 521-527
87. Konstantinopoulos, P. A.; Kominea, A.; Vandoros, G.; Sykiotis, G. P.; Andricopoulos, P.; Varakis, I.; Sotiropoulou-Bonikou, G.; Papavassiliou, A. G. Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation Eur. J. Cancer 2003, 39, 1251-1258
88. Bardin, A.; Boulle, N.; Lazennec, G.; Vignon, F.; Pujol, P. Loss of ERβ expression as a common step in estrogen-dependent tumor progression Endocr. Relat. Cancer 2004, 11, 537-551
89. Foley, E. F.; Jazaeri, A. A.; Shupnik, M. A.; Jazaeri, O.; Rice, L. W. Selective loss of estrogen receptor β in malignant human colon Cancer Res. 2000, 60, 245-248
90. Berner, C.; Aumüller, E.; Gnauck, A.; Nestelberger, M.; Just, A.; Haslberger, A. G. Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds Ann. Nutr. Metab. 2010, 57, 183-189
91. Schleipen, B.; Hertrampf, T.; Fritzemeier, K. H.; Kluxen, F. M.; Lorenz, A.; Molzberger, A.; Velders, M.; Diel, P. ERβ-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine Carcinogenesis 2011, 32 (11) 1675-1683
92. Giroux, V.; Bernatchez, G.; Carrier, J. C. Chemopreventive effect of ERβ-selective agonist on intestinal tumorigenesis in Apc(Min/+) mice Mol. Carcinog. 2011, 50, 359-369
93. Bulzomi, P.; Galluzzo, P.; Bolli, A.; Leone, S.; Acconcia, F.; Marino, M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals J. Cell Physiol. 2012, 227 (5) 1891-1898
94. Aehle, E.; Müller, U.; Eklund, P. C.; Willför, S. M.; Sippl, W.; Dräger, B. Lignans as food constituents with estrogen and antiestrogen activity Phytochemistry 2011, 72 (18) 2396-2405
95. Hogan, A. M.; Collins, D.; Sheehan, K.; Zierau, O.; Baird, A. W.; Winter, D. C. Rapid effects of phytoestrogens on human colonic smooth muscle are mediated by oestrogen receptor β Mol. Cell. Endocrinol. 2010, 320, 106-110
96. Hogan, A. M.; Collins, D.; Baird, A. W.; Winter, D. C. Estrogen and gastrointestinal malignancy Mol. Cell. Endocrinol. 2009, 307, 19-24
97. Yang, C. S.; Wang, H. Mechanistic issues concerning cancer prevention by tea catechins Mol. Nutr. Food Res. 2011, 55, 819-831
98. Clarke, J. D.; Dashwood, R. H.; Ho, E. Multi-targeted prevention of cancer by sulforaphane Cancer Lett. 2008, 269, 291-304
99. Pan, M. H.; Lai, C. S.; Wu, J. C.; Ho, C. T. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds Mol. Nutr. Food Res. 2011, 55, 32-45
100. Romagnolo, D. F.; Papoutsis, A. J.; Selmin, O. Nutritional targeting of cyclooxygenase-2 for colon cancer prevention Inflamm. Allergy Drug Targets 2010, 9, 181-191